Response to: Adrenal haemorrhage and COVID-19 vaccine-induced immune thrombotic thrombocytopenia: correspondence
QJM
.
2022 Dec 12;115(12):876-877.
doi: 10.1093/qjmed/hcac007.
Authors
Chia-Yi Lin
1
,
Chung-Chi Yang
2
3
,
Li-Yen Huang
2
3
,
Kuo-An Wu
4
,
Jenq-Shyong Chan
5
6
,
Wen-Fang Chiang
5
6
,
Kun-Lin Wu
5
6
,
Hann-Yen Shyu
7
,
Yung-Hsi Kao
8
,
Po-Jen Hsiao
5
6
8
Affiliations
1
From the Department of Internal Medicine, Taoyuan Armed Forces General Hospital, Taoyuan 325, Taiwan.
2
Division of Cardiology, Department of Internal Medicine, Taoyuan Armed Forces General Hospital, Taoyuan 325, Taiwan.
3
Division of Cardiology, Department of Internal Medicine, Tri-Service General Hospital, National Defense Medical Center, Taipei 114, Taiwan.
4
Division of Pulmonary & Critical Care Medicine, Taoyuan Armed Forces General Hospital, Taoyuan 325, Taiwan.
5
Division of Neurology, Department of Internal Medicine, Taoyuan Armed Forces General Hospital, Taoyuan 325, Taiwan.
6
Division of Nephrology, Department of Internal Medicine, Taoyuan Armed Forces General Hospital, Taoyuan 325, Taiwan.
7
Division of Nephrology, Department of Internal Medicine, Tri-Service General Hospital, National Defense Medical Center, Taipei 114, Taiwan.
8
Department of Life Sciences, National Central University, Taoyuan 320, Taiwan.
PMID:
35038745
PMCID:
PMC8807221
DOI:
10.1093/qjmed/hcac007
No abstract available
Publication types
Comment
MeSH terms
Adrenal Gland Diseases*
COVID-19 Vaccines* / adverse effects
COVID-19*
Hemorrhage / etiology
Humans
Thrombocytopenia* / chemically induced
Thrombosis*
Substances
COVID-19 Vaccines